AquaBounty Technologies Inc is a biotechnology company. It is engaged in research, development, and commercialization of the commercial viability of a group of proteins, antifreeze proteins. The company primarily focuses on the managing aquaculture productivity. Its lead product is the AquAdvantage Salmon, a genetically modified animal for human consumption. Geographically, all the operation of the group is functioned through the region of US and it derives revenue from the sale of AquAdvantage Salmon.